Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Clinical Pharmacology
|
January 21, 2025
Risk of bias tools for medication adherence research: RoBIAS and RoBOAS
Klarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
Therapeutic Drug Monitoring
|
December 31, 2014
Methods for Predicting Warfarin Dose Requirements
Shamin M Saffian, Daniel F B Wright, Rebecca L Roberts, et al.
Research in Social & Administrative Pharmacy : RSAP
|
May 6, 2017
A philosophical framework for pharmacy in the 21st century guided by ethical principles
Stephen B Duffull, Daniel F B Wright, Carlo A Marra, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
Vijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports
|
August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarin
Qing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology
|
June 11, 2020
Understanding the association between metformin plasma concentrations and lactate
Isabelle H S Kuan, Daniel F B Wright, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology
|
February 25, 2025
Alternative splicing with CYP3A4*22: Implications for the steroid-tacrolimus drug interaction
Jana Stojanova, Nuala Ann Helsby, Daniel F B Wright, et al.
Journal of the American College of Cardiology
|
April 1, 2014
Learning more from the dabigatran concentrations in the RE-LY study
Paul K L Chin, Daniel F B Wright, Matthew P Doogue, et al.
British Journal of Clinical Pharmacology
|
November 3, 2010
Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths)
Daniel F B Wright, Hesham S Al-Sallami, Pamela M Jackson, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model
Daniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Clinical Pharmacology
|
January 21, 2025
Risk of bias tools for medication adherence research: RoBIAS and RoBOAS
Klarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
Therapeutic Drug Monitoring
|
December 31, 2014
Methods for Predicting Warfarin Dose Requirements
Shamin M Saffian, Daniel F B Wright, Rebecca L Roberts, et al.
Research in Social & Administrative Pharmacy : RSAP
|
May 6, 2017
A philosophical framework for pharmacy in the 21st century guided by ethical principles
Stephen B Duffull, Daniel F B Wright, Carlo A Marra, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
Vijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports
|
August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarin
Qing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology
|
June 11, 2020
Understanding the association between metformin plasma concentrations and lactate
Isabelle H S Kuan, Daniel F B Wright, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology
|
February 25, 2025
Alternative splicing with CYP3A4*22: Implications for the steroid-tacrolimus drug interaction
Jana Stojanova, Nuala Ann Helsby, Daniel F B Wright, et al.
Journal of the American College of Cardiology
|
April 1, 2014
Learning more from the dabigatran concentrations in the RE-LY study
Paul K L Chin, Daniel F B Wright, Matthew P Doogue, et al.
British Journal of Clinical Pharmacology
|
November 3, 2010
Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths)
Daniel F B Wright, Hesham S Al-Sallami, Pamela M Jackson, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model
Daniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
Page
of 8